| Jason Warncke, MD | |
|
6767 29th St Fl 2, Greeley, CO 80634-5474 | |
| (970) 652-2491 | |
| (970) 652-2492 |
| Full Name | Jason Warncke |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 11 Years |
| Location | 6767 29th St Fl 2, Greeley, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073956942 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | DR.0062687 (Colorado) | Primary |
| 208800000X | Urology | TL 0004631 (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uchealth Greeley Hospital | Greeley, CO | Hospital |
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Medical Center Of The Rockies | Loveland, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rocky Mountain Lithotripter Llc | 5395737985 | 8 |
| Poudre Valley Medical Group Llc | 9638208549 | 1605 |
News Archive
Acute myeloid leukemia (AML) is an aggressive blood cancer that is currently incurable in 70% of patients. In a bold effort, CSHL scientists are among those identifying and characterizing the molecular mechanisms responsible for this cancer in order to generate potential new therapeutics.
A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
Children may be receiving the highest exposure to nanoparticles of titanium dioxide in candy, which they eat in amounts much larger than adults, according to a new study. Published in ACS' journal, Environmental Science & Technology, it provides the first broadly based information on amounts of the nanomaterial - a source of concern with regard to its potential health and environmental effects - in a wide range of consumer goods.
Ipsen and Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced that they have entered into a partnership to create a world leading hemophilia franchise. The partnership is designed to leverage combined expertise and resources to advance a broad portfolio of recombinant proteins, which address all major hemophilia disorders in a unique way by focusing on two significant unmet needs: wider access to treatment with coagulation factors and treatment for inhibitor complications.
› Verified 9 days ago
| Entity Name | Rocky Mountain Lithotripter Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134202435 PECOS PAC ID: 5395737985 Enrollment ID: O20040401001756 |
News Archive
Acute myeloid leukemia (AML) is an aggressive blood cancer that is currently incurable in 70% of patients. In a bold effort, CSHL scientists are among those identifying and characterizing the molecular mechanisms responsible for this cancer in order to generate potential new therapeutics.
A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
Children may be receiving the highest exposure to nanoparticles of titanium dioxide in candy, which they eat in amounts much larger than adults, according to a new study. Published in ACS' journal, Environmental Science & Technology, it provides the first broadly based information on amounts of the nanomaterial - a source of concern with regard to its potential health and environmental effects - in a wide range of consumer goods.
Ipsen and Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced that they have entered into a partnership to create a world leading hemophilia franchise. The partnership is designed to leverage combined expertise and resources to advance a broad portfolio of recombinant proteins, which address all major hemophilia disorders in a unique way by focusing on two significant unmet needs: wider access to treatment with coagulation factors and treatment for inhibitor complications.
› Verified 9 days ago
| Entity Name | Poudre Valley Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366763260 PECOS PAC ID: 9638208549 Enrollment ID: O20100602000122 |
News Archive
Acute myeloid leukemia (AML) is an aggressive blood cancer that is currently incurable in 70% of patients. In a bold effort, CSHL scientists are among those identifying and characterizing the molecular mechanisms responsible for this cancer in order to generate potential new therapeutics.
A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
Children may be receiving the highest exposure to nanoparticles of titanium dioxide in candy, which they eat in amounts much larger than adults, according to a new study. Published in ACS' journal, Environmental Science & Technology, it provides the first broadly based information on amounts of the nanomaterial - a source of concern with regard to its potential health and environmental effects - in a wide range of consumer goods.
Ipsen and Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced that they have entered into a partnership to create a world leading hemophilia franchise. The partnership is designed to leverage combined expertise and resources to advance a broad portfolio of recombinant proteins, which address all major hemophilia disorders in a unique way by focusing on two significant unmet needs: wider access to treatment with coagulation factors and treatment for inhibitor complications.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Warncke, MD 6767 29th St Fl 2, Greeley, CO 80634-5474 Ph: (970) 652-2491 | Jason Warncke, MD 6767 29th St Fl 2, Greeley, CO 80634-5474 Ph: (970) 652-2491 |
News Archive
Acute myeloid leukemia (AML) is an aggressive blood cancer that is currently incurable in 70% of patients. In a bold effort, CSHL scientists are among those identifying and characterizing the molecular mechanisms responsible for this cancer in order to generate potential new therapeutics.
A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
Children may be receiving the highest exposure to nanoparticles of titanium dioxide in candy, which they eat in amounts much larger than adults, according to a new study. Published in ACS' journal, Environmental Science & Technology, it provides the first broadly based information on amounts of the nanomaterial - a source of concern with regard to its potential health and environmental effects - in a wide range of consumer goods.
Ipsen and Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced that they have entered into a partnership to create a world leading hemophilia franchise. The partnership is designed to leverage combined expertise and resources to advance a broad portfolio of recombinant proteins, which address all major hemophilia disorders in a unique way by focusing on two significant unmet needs: wider access to treatment with coagulation factors and treatment for inhibitor complications.
› Verified 9 days ago
Gary Dean Eastes, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1801 16th St, Greeley, CO 80631 Phone: 970-392-2026 Fax: 970-392-2027 | |
Dr. Kevin Michael Clay, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5881 W 16th St, Suite D, Greeley, CO 80634 Phone: 970-353-1551 Fax: 970-350-2478 | |
David F Ritsema, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 5890 W 13th St, Suite 106, Greeley, CO 80634 Phone: 970-378-1000 Fax: 970-378-1899 | |
Dr. Phillip Stephen Kick, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5881 W 16th St, Greeley, CO 80634 Phone: 970-353-1551 Fax: 970-350-2478 | |
Curtis E Crylen, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5890 W 13th Street, Suite 106, Greeley, CO 80634 Phone: 970-378-1000 Fax: 970-378-1899 | |
James William Wolach, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5890 W 13th St, Suite 106, Greeley, CO 80634 Phone: 970-378-1000 Fax: 970-378-1899 |